Anti-CD40 antibodies exert tumor-suppressive effects by engaging tumor-infiltrating macrophages and increasing levels of CCL2 and IFNγ, thereby enhancing tumor cell elimination [60–62]. This evidence concerns the gene CCL2 and neoplasm.